Bio-Rad Laboratories, Inc. Class A Common Stock vs Vistra Corp — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while Vistra Corp trades at $145.99 (market cap $48.64B). The key difference: Vistra Corp is far larger — about 5.2× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and Vistra Corp pays a 0.63% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | VST | |
|---|---|---|
Market Cap | $9.43B | $48.64B |
Sector | Health | Technology |
52-Week High | $356.25 | $217.92 |
52-Week Low | $241.71 | $134.71 |
Enterprise Value | $9.18B | $70.58B |
Dividend Yield | — | 0.63% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →Vistra is a leading integrated retail electricity and power generation company that serves as a critical infrastructure provider for the digital economy. It operates a diversified portfolio of zero-carbon nuclear and renewable assets alongside a massive, flexible natural gas fleet, positioning it as an indispensable partner for energy-intensive AI data centers and industrial electrification.
Read more on VST →